Skip to content
NHS South West London logo

Main Navigation

  • Home
  • About us
  • Your area
    • Croydon
  • Policies
    • Commissioning
    • Individual Funding Request (IFR)
    • Pharmaceutical Offers
    • Prescribing: Hospital or specialist only medicines
    • Prescribing: Interface policy
    • Prescribing: Agreement for shared care, transfer of care and notification of initiation
    • Position Statements
  • Clinical Guidance
    • 1. Gastro-intestinal System
    • 2. Cardiovascular System
    • 3. Respiratory System
    • 4 Central Nervous System
    • 5. Infections
    • 6. Endocrine System
    • 7. Obstetric, Gynaecology, and Urinary Tract Disorders
    • 9. Nutrition and Blood
    • 10. Musculoskeletal & Joint Diseases
    • 11. Eye
    • 13. Skin
    • 14. Vaccines and Immunisations
    • 26. A5: Wound Management
    • Renal
    • Self Care Guidance for Clinicians
    • Pharmacy First Service
  • Information for patients
    • Discharge Medicines Service (DMS)
    • Managing your Medicines and Appliances
    • Medicines of limited clinical value
    • Self Care
  • Contact us
  • Notification of Initiation Forms
  • Shared Care Agreements
  • Transfer of Care Agreements

Notification of Initiation Forms

DOAC: Rivaroxaban for acute coronary syndrome

DOAC: Stroke prevention in non-valvular atrial fibrillation

DOAC: Venous thromboembolism

Sacubitril valsartan for the treatment of heart failure

Website managed by SWL Medicines Optimisation Document Governance Team
NHS South West London Integrated Care Board
120 The Broadway
Wimbledon SW19 1RH
  • Privacy policy
  • Cookie policy
  • Accessibility statement
  • Google Translate
Site designed by NECS Design Solutions